PerkinElmer announced a deal to buy Belgium's Euroscreen Products for an undisclosed sum. Euroscreen markets products to laboratories engaged in drug discovery work. This is ElmerPerkin's seventh acquisition of the year. "This transaction would represent the next step in our strategy to build the most comprehensive offering in cellular screening and drug discovery reagent technologies," said PerkinElmer chairman and chief executive Gregory L. Summe.
- read the report on the acquisition from The Boston Globe